These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19164263)

  • 61. An exploratory study of a novel peritoneal combination dialysate (1.36% glucose/7.5% icodextrin), demonstrating improved ultrafiltration compared to either component studied alone.
    Jenkins SB; Wilkie ME
    Perit Dial Int; 2003; 23(5):475-80. PubMed ID: 14604201
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Icodextrin preserves residual renal function in patients treated with automated peritoneal dialysis.
    Adachi Y; Nakagawa Y; Nishio A
    Perit Dial Int; 2006; 26(3):405-7. PubMed ID: 16722036
    [No Abstract]   [Full Text] [Related]  

  • 63. Icodextrin with small and short dwell enhances ultrafiltration in peritoneal dialysis patients with severe overhydration.
    Kuriyama S; Otsuka Y; Iida R; Matsumoto K; Hosoya T
    Perit Dial Int; 2006; 26(4):508-9. PubMed ID: 16881350
    [No Abstract]   [Full Text] [Related]  

  • 64. Effects of icodextrin peritoneal dialysis solution on the peritoneal membrane in the STZ-induced diabetic rat model with partial nephrectomy.
    Nakao A; Nakao K; Takatori Y; Kojo S; Inoue J; Akagi S; Sugiyama H; Wada J; Makino H
    Nephrol Dial Transplant; 2010 May; 25(5):1479-88. PubMed ID: 19759273
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Peritoneal dialysis solution and nutrition.
    Verger C
    Contrib Nephrol; 2012; 178():6-10. PubMed ID: 22652708
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Effect of using icodextrin as a starting therapy for peritoneal permeability].
    Fernández-Reyes MJ; Bajo MA; del Peso G; Olea T; Sánchez-Villanueva RL; González E; Heras M; Sánchez R; Selgas R
    Nefrologia; 2009; 29(2):130-5. PubMed ID: 19396318
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of icodextrin on patient survival and technique success in patients undergoing peritoneal dialysis.
    Han SH; Ahn SV; Yun JY; Tranaeus A; Han DS
    Nephrol Dial Transplant; 2012 May; 27(5):2044-50. PubMed ID: 21968011
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cost savings from peritoneal dialysis therapy time extension using icodextrin.
    Johnson DW; Vincent K; Blizzard S; Rumpsfeld M; Just P
    Adv Perit Dial; 2003; 19():81-5. PubMed ID: 14763039
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of peritoneal dialysis solution type on serum lipid levels in end-stage renal disease.
    Kanbay M; Bavbek N; Delibasi T; Koca C; Kaya A; Altay M; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2007; 29(3):309-13. PubMed ID: 17497445
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of icodextrin in automated peritoneal dialysis on blood pressure and bioelectrical impedance analysis.
    Woodrow G; Oldroyd B; Stables G; Gibson J; Turney JH; Brownjohn AM
    Nephrol Dial Transplant; 2000 Jun; 15(6):862-6. PubMed ID: 10831642
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of icodextrin on glycemic and lipid profiles in diabetic patients undergoing peritoneal dialysis.
    Babazono T; Nakamoto H; Kasai K; Kuriyama S; Sugimoto T; Nakayama M; Hamada C; Furuya R; Hasegawa H; Kasahara M; Moriishi M; Tomo T; Miyazaki M; Sato M; Yorioka N; Kawaguchi Y;
    Am J Nephrol; 2007; 27(4):409-15. PubMed ID: 17622748
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Does peritoneal dialysis predispose a diabetic patient to icodextrin-induced peritonitis?
    Fiedler R; Schneider I; Buchmann J; Osten B; Langer T
    Nephrol Dial Transplant; 2002 Sep; 17(9):1708-9. PubMed ID: 12198234
    [No Abstract]   [Full Text] [Related]  

  • 73. Icodextrin re-absorption varies with age in children on automated peritoneal dialysis.
    Dart A; Feber J; Wong H; Filler G
    Pediatr Nephrol; 2005 May; 20(5):683-5. PubMed ID: 15719251
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Peritoneal accumulation of advanced glycosylation end-products in diabetic rats on dialysis with icodextrin.
    Lee JH; Reddy DK; Saran R; Moore HL; Twardowski ZJ; Nolph KD; Khanna R
    Perit Dial Int; 2000; 20 Suppl 5():S39-47. PubMed ID: 11229611
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Favorable changes in lipid metabolism and cardiovascular parameters after icodextrin use in peritoneal dialysis patients.
    Hiramatsu T; Furuta S; Kakuta H
    Adv Perit Dial; 2007; 23():58-61. PubMed ID: 17886604
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A novel "bimodal" use of icodextrin peritoneal dialysis solutions.
    Burkart J
    Kidney Int; 1998 Apr; 53(4):1089-90. PubMed ID: 9551423
    [No Abstract]   [Full Text] [Related]  

  • 77. Icodextrin provides long dwell peritoneal dialysis and maintenance of intraperitoneal volume.
    Peers E; Gokal R
    Artif Organs; 1998 Jan; 22(1):8-12. PubMed ID: 9456219
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study.
    Konings CJ; Kooman JP; Schonck M; Gladziwa U; Wirtz J; van den Wall Bake AW; Gerlag PG; Hoorntje SJ; Wolters J; van der Sande FM; Leunissen KM
    Kidney Int; 2003 Apr; 63(4):1556-63. PubMed ID: 12631373
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Icodextrin and intraperitoneal inflammation.
    Moriishi M; Kawanishi H
    Perit Dial Int; 2008 Jun; 28 Suppl 3():S96-S100. PubMed ID: 18552274
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Icodextrin effluent leads to a greater proliferation than glucose effluent of human mesothelial cells studied ex vivo.
    Bajo MA; Selgas R; Castro MA; del Peso G; Diaz C; Sánchez-Tomero JA; Fernandez de Castro M; Alvarez V; Corbí A
    Perit Dial Int; 2000; 20(6):742-7. PubMed ID: 11216569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.